Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Costs At a Decade Low, Ireland Pitches To Indian Companies For Long-term Investments

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Has the global meltdown triggered in 2008 made Europe a competitive destination for investments in manufacturing facilities? That question made rounds amongst a few large Indian pharmaceutical companies as leading executives from the Industrial Development Authority of Ireland pitched to funnel long-term investments from Indian generic drug makers

You may also be interested in...



Daiichi Sankyo Forms Ireland Marketing Subsidiary, Continues European Push

TOKYO - Daiichi Sankyo said Nov. 26 that its German subsidiary, Daiichi Sankyo Europe, has formed a sales subsidiary in Dublin, Ireland for marketing its core products by obtaining Merck Serono's cardiometabolic sales force there

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

LL1127674

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel